• Skip to main content
  • Skip to secondary menu
  • Skip to primary sidebar
  • Skip to secondary sidebar
  • Skip to footer

  • Opinion
  • Health IT
    • Behavioral Health
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Patient Engagement
    • Population Health Management
    • Revenue Cycle Management
    • Social Determinants of Health
  • Digital Health
    • AI
    • Blockchain
    • Precision Medicine
    • Telehealth
    • Wearables
  • Life Sciences
  • Investments
  • M&A
  • Value-based Care
    • Accountable Care (ACOs)
    • Medicare Advantage

ConcertAI Acquires CancerLinQ to Expand Real-World Data and AI Solutions for Cancer Care

by Fred Pennic 12/11/2023 Leave a Comment

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

What You Should Know:

– ConcertAI, a developer of AI-powered healthcare solutions, announced today the acquisition of CancerLinQ, a subsidiary of the American Society of Clinical Oncology (ASCO).

– This strategic move will significantly enhance and expand CancerLinQ’s capabilities, unlocking the potential of real-world data and next-generation AI to revolutionize cancer care and accelerate clinical research.

CancerLinQ Background

CancerLinQ represents one of the largest oncology real-world data and quality of care technology services entities in the world. With access to data from nearly seven million patients across a network of over 100 cancer centers and oncology practices, CancerLinQ empowers healthcare professionals with data-driven insights to improve care delivery and research outcomes.

CancerLinQ Acquisition Benefits

Building on CancerLinQ’s existing strengths, the acquisition will:

– Expand CancerLinQ’s real-world data platform: ConcertAI will invest more than $250 million over the next few years to integrate additional data sources into the platform, providing a broader and deeper understanding of cancer patients and their care.

– Develop innovative clinical trial solutions: By leveraging ConcertAI’s Digital Access to Clinical Trial (DACT) platform, CancerLinQ will facilitate patient participation in clinical trials, making it more accessible and less burdensome.

– Enhance clinical decision support tools: The combined expertise of ConcertAI and ASCO will lead to the development of more robust clinical decision support tools within the SmartLinQ™ platform, empowering physicians to make informed treatment decisions.

– Streamline data integration: Automated EMR integration will be implemented, seamlessly incorporating SmartLinQ into existing practice workflows.

This collaboration is expected to deliver significant benefits for various stakeholders:

– Oncology practices: Enhanced SmartLinQ™ platform, improved access to clinical trials, and streamlined data integration.

– Patients: Better access to treatment options, improved care quality, and more personalized treatment plans.

– Researchers: Faster development of new drugs and therapies through access to a vast and diverse pool of real-world data.

“We believe this agreement will provide the resources to fulfill and amplify CancerLinQ’s impact,” said Dr. Clifford A. Hudis, MD, FACP, FASCO, Chief Executive Officer of ASCO. “We expect CancerLinQ to be an important avenue for practices to achieve certification under ASCO’s recently launched ASCO Certified program.”

  • LinkedIn
  • Twitter
  • Facebook
  • Email
  • Print

Tagged With: Artificial Intelligence, CancerLinQ, Healthcare Mergers & Acquisitions, Oncology, real-world data (RWD)

Tap Native

Get in-depth healthcare technology analysis and commentary delivered straight to your email weekly

Reader Interactions

Primary Sidebar

Subscribe to HIT Consultant

Latest insightful articles delivered straight to your inbox weekly.

Submit a Tip or Pitch

HLTH 2025 Coverage

HLTH 2025 Day 1 Summary & Insights: AMA Launches AI Governance Center, Google Cloud, Microsoft, ChatGPT for Medicine

Featured Interview

ConcertAI VP Shares View on AI Hallucinations and the Fabricated Data Crisis in Scientific Publishing

Most-Read

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Cleveland Clinic and Khosla Ventures Form Strategic Alliance to Accelerate Healthcare Innovation

Northwell Health Selects to Deploy Abridge’s Ambient AI Across 28 Hospitals

Northwell Health to Deploy Abridge’s Ambient AI Across 28 Hospitals

Omada Health Launches "Nutritional Intelligence" with AI Agent OmadaSpark

Omada Health Launches AI-Powered Meal Map to Transform Nutrition for Cardiometabolic Patients

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

From Overwhelmed to Optimized: How AI Agents Address Staffing Challenges and Burnout in Healthcare

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Qualtrics Acquires Press Ganey Forsta for $6.75B to Create the Most Comprehensive AI Experience Platform

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

Pfizer and Trump Administration Announce Landmark Agreement to Lower Drug Costs

KLAS Report: Epic's Native Ambient Speech Tool Reshapes Customer AI Strategies

KLAS Report: Epic’s Native Ambient Speech Tool Reshapes Customer AI Strategies

Epic Unveils MyChart Central and New APIs to Advance Interoperability at Open@Epic

Epic Outlines Roadmap for Next-Generation Data Sharing at Open@Epic

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

Epic Launches Comet: A New AI Platform to Predict Patient Health Journeys

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

RevSpring to Acquire Kyruus Health, Creating a Unified Patient Experience

Secondary Sidebar

Footer

Company

  • About Us
  • Advertise with Us
  • Reprints and Permissions
  • Op-Ed Submission Guidelines
  • Contact
  • Subscribe

Editorial Coverage

  • Opinion
  • Health IT
    • Care Coordination
    • EMR/EHR
    • Interoperability
    • Population Health Management
    • Revenue Cycle Management
  • Digital Health
    • Artificial Intelligence
    • Blockchain Tech
    • Precision Medicine
    • Telehealth
    • Wearables
  • Startups
  • Value-Based Care
    • Accountable Care
    • Medicare Advantage

Connect

Subscribe to HIT Consultant Media

Latest insightful articles delivered straight to your inbox weekly

Copyright © 2025. HIT Consultant Media. All Rights Reserved. Privacy Policy |